Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration-resistant Prostate Cancer Metastatic to Bone”

109 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 109 results

Early research (Phase 1)WithdrawnNCT02396368
What this trial is testing

Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate CancerBone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Ended earlyNCT02565901
What this trial is testing

Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v7+1 more
University of Washington 28
Large-scale testing (Phase 3)Active Not RecruitingNCT02194842
What this trial is testing

Phase III Radium 223 mCRPC-PEACE III

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 446
Testing effectiveness (Phase 2)Active Not RecruitingNCT05924672
What this trial is testing

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneStage IVB Prostate Cancer AJCC v8
University of California, San Francisco 2
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Not applicableStudy completedNCT01833208
What this trial is testing

Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Ended earlyNCT03442556
What this trial is testing

Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

Who this might be right for
ATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+7 more
University of Washington 18
Not applicableStudy completedNCT01160705
What this trial is testing

Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

Who this might be right for
Metastatic CancerProstate Cancer
Cancer Trials Ireland 73
Testing effectiveness (Phase 2)Study completedNCT01091103
What this trial is testing

Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide

Who this might be right for
Metastatic Progressive Castration-resistant Prostate Cancer
Pfizer 60
Testing effectiveness (Phase 2)Study completedNCT02346526
What this trial is testing

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerCastration-resistant Prostate Cancer Metastatic to Bone
Massachusetts General Hospital 22
Not applicableStudy completedNCT03223597
What this trial is testing

Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223

Who this might be right for
Prostate Cancer MetastaticBone Metastases
The Netherlands Cancer Institute 300
Large-scale testing (Phase 3)Active Not RecruitingNCT02051218
What this trial is testing

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Who this might be right for
Metastatic Breast CancerMetastatic Prostate CancerBone Metastases
Swiss Cancer Institute 1,380
Testing effectiveness (Phase 2)Study completedNCT01934790
What this trial is testing

Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases

Who this might be right for
Prostatic Neoplasms
Bayer 45
Testing effectiveness (Phase 2)UnknownNCT03305224
What this trial is testing

The Combination Therapy With Ra-223 and Enzalutamide

Who this might be right for
Castration-resistant Prostate CancerBone Metastases
Taro Iguchi, MD, PHD 10
Early research (Phase 1)Study completedNCT01565746
What this trial is testing

Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients

Who this might be right for
Prostatic Neoplasms
Bayer 19
Testing effectiveness (Phase 2)WithdrawnNCT07025512
What this trial is testing

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

Who this might be right for
Metastatic Castration Resistant Prostate CancerCytopeniaAnemia+1 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT02803437
What this trial is testing

Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bayer 334
Testing effectiveness (Phase 2)Study completedNCT01074138
What this trial is testing

Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Bone-Metastatic, Castration-Resistant Prostate Cancer
Athenex, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT01929655
What this trial is testing

Japanese BAY88-8223 Monotherapy Phase II Study

Who this might be right for
Prostatic Neoplasms
Bayer 49
Testing effectiveness (Phase 2)Study completedNCT02463799
What this trial is testing

Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Next Page